Document Mentions (3 shared documents)

EFTA00090721

3 mentions1 same-page

Page ?Same page

f that it is what its proponent says it is. The requirement of authentication is thus a condition precedent to admitting evidence." United States v. Sliker, 751 F.2d 477, 497 (2d Cir. 1984). A motion in limine to preclude evidence calls on the "[C]ourt to make a preliminary determination on the admissi

Schneider, No. CRIM.A. 10-29, 2010 WL 3734055 (E.D. Pa. Sept. 22, 2010) 20, Sena, No. 19-CR-01432, 2021 WL 4129247 (D.N.M. Sept. 9, 2021) 39, 40 Sliker, 751 F.2d 477 (2d Cir.1984) 41 Smalls, No. CR 06-2403 RB, 2008 WL 11361098 (D.N.M. Jan. 24, 2008) 3 Stein, 521 F. Supp. 2d 266 (S.D.N.Y. 2007) 3

Dow Phanns., Inc., 509 U.S. 579 (1993) passim Dougherty v. County of Sttffolk,No. CV 13-6493 (AKT), 2018 WL 1902336 (E.D.N.Y. Apr. 20, 2018) 41 Esquivel-Quintana v. Sessions, 137 S. Ct. 1562 (2017) 30 Highland Capital Mgmt., L.P. v. Schneider, 379 F. Supp. 2d 461 (S.D.N.Y. 2005) 41 Lou v. United States, 218 F.2d 675 (

EFTA00074479

2 mentions1 same-page

Page ?Same page

States v. Nektalov, 325 F. Supp. 2d 367 (S.D.N.Y. 2004) 6, 8, 9, 10 United States v. Pascarella, 84 F.3d 61 (2d Cir. 1996) 11 United States v. Sliker, 751 F.2d 477 (2d Cir. 1984) 12 United States v. Townsend, No. S1 06 CR. 34 (JFK), 2007 WL 1288597 (S.D.N.Y. May 1, 2007) 6, 9, 10 United State

14 CONCLUSION 16 i EFTA00074480 TABLE OF AUTHORITIES Page(s) Cases Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) 12 Esquivel-Quintana v. Sessions, 137 S. Ct. 1562 (2017) 14 Grunewald v. United States, 353 U.S. 391 (1957) 8 Huddleston v. United States, 485 U.S. 681 (1988) 5, 6 Salinas v

EFTA00087774

2 mentions1 same-page

Page ?Same page

14 CONCLUSION 16 i EFTA00087775 TABLE OF AUTHORITIES Page(s) Cases Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) 12 Esquivel-Quintana v. Sessions, 137 S. Ct. 1562 (2017) 14 Grunewald v. United States, 353 U.S. 391 (1957) 8 Huddleston v. United States, 485 U.S. 681 (1988) 5, 6 Salinas v